Screening of Specific Genes for Pigmented Villous Nodular Synovitis

Status Completed

Clinical Trial Summary

This study retrospectively analyzed the history of present illness of PVNS patients in our hospital. The enrolled patients were followed up by telephone to follow up their postoperative recovery and living conditions. Take the patient's pathological specimens for immunohistochemical testing, evaluate the relationship between the expression of different molecular targets, clinical manifestations and patient prognosis, and explore new molecular targets related to disease diagnosis and treatment.

Clinical Trial Description

This study retrospectively analyzed the symptoms, time of onset, injury history, laboratory examinations, imaging examinations, and intraoperative conditions of PVNS patients in our hospital. The enrolled patients were followed up by telephone to follow up their postoperative recovery and living conditions (VAS score, SF-36 score). Take the patient's pathological specimens for immunohistochemical testing, evaluate the relationship between the expression of different molecular targets, clinical manifestations and patient prognosis, and explore new molecular targets related to disease diagnosis and treatment. ;

Study Design

Related Conditions & MeSH terms

Pigmented Villonodular Synovitis
Synovitis
Synovitis, Pigmented Villonodular

Clinical Trial Details

NCT number	NCT04955535
Study type	Observational
Source	Peking University Third Hospital
Contact
Status	Completed
Phase
Start date	August 3, 2020
Completion date	December 27, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01207492` - Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor	Phase 2
Terminated	`NCT04938180` - A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients	Phase 2
Active, not recruiting	`NCT05059262` - Study of Vimseltinib for Tenosynovial Giant Cell Tumor	Phase 3
Active, not recruiting	`NCT04731675` - An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee	Phase 2
Completed	`NCT02371369` - Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)	Phase 3
Completed	`NCT02471716` - Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor	Phase 1/Phase 2
Recruiting	`NCT05349643` - A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT	Phase 2
Completed	`NCT04952896` - Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease
Active, not recruiting	`NCT03069469` - Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor	Phase 1/Phase 2
Completed	`NCT01261429` - Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)	Phase 2
Active, not recruiting	`NCT05804045` - Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)	Phase 3
Completed	`NCT01643850` - MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)	Phase 2